Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities
Crossref DOI link: https://doi.org/10.1057/jphp.2016.8
Published Online: 2016-08-01
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liberti, Lawrence
Breckenridge, Alasdair
Hoekman, Jarno
Leufkens, Hubert
Lumpkin, Murray
McAuslane, Neil
Stolk, Pieter
Zhi, Kaining
Rägo, Lembit
Text and Data Mining valid from 2016-08-01